BHP Group will begin settling 30% of its spot iron-ore sales to China in renminbi from Q4 2025, a quiet but consequential currency shift.
The commercial significance is clear in iron-ore market structure. Fifteen years ago, then-CEO Marius Kloppers moved the trade off the annual benchmark and onto spot index pricing, which effectively anchored settlements in US dollars.
The new arrangement loosens that dollar anchor by normalizing RMB settlement for a material share of China-bound spot volumes.
For counterparties, the near-term operational change is invoice currency on eligible spot shipments from Q4 2025. Price discovery still references prevailing indices, but settlement for the covered share flips to RMB. That narrows the gap between China’s dominant role in processing and its historical lack of control over payment currency, aligning trade flows more tightly with China’s financial plumbing.
Sponsored · Altamira Gold Corp.
Meanwhile, long-term 2026 contracts remain USD-denominated. No formal BHP guidance accompanied the shift, and the announcement timing came without executive commentary.
The move lands amid ongoing price- and terms-related negotiations between BHP and China Mineral Resources Group, where industry coverage has flagged frictions that could extend into 2026.
Peers like Rio Tinto and other suppliers with large China exposure may now face competitive pressure to evaluate whether RMB settlement on spot trades becomes a commercial expectation in tenders once liquidity and hedging depth are demonstrably sufficient.
Financing signals are already rhyming with the trade shift. Two months before BHP’s settlement decision surfaced, Fortescue secured a RMB 14.2 billion (around US$2 billion) China-syndicated term loan, underscoring on-shore RMB liquidity available to Australian miners.
The RMB settlement reports emerged just ahead of US–Australia meetings in Washington where AUKUS and defense-industrial ties are on the agenda.
Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
